Substudy - Low Dose of Abatacept in Subjects With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this exploratory sub-study was to evaluate from a clinical perspective the
impact on disease activity of lowering the dose of abatacept from 10 mg/kg to 5 mg/kg in
subjects who had achieved remission (Disease Activity Score 28 [DAS 28]-erythrocyte
sedimentation rate [ESR] < 2.6) at Day 701 of study IM101023.